Patients with kidney disease are at increased risk for a range of respiratory complications due to the complex interplay between renal dysfunction, fluid imbalance, and systemic inflammation. Respiratory complications in kidney disease commonly include pulmonary edema, pleural effusions, sleep-disordered breathing, and an increased susceptibility to infections such as pneumonia. Impaired renal function can lead to fluid retention, electrolyte disturbances, and acid-base imbalances, all of which can compromise lung mechanics and gas exchange. Effective management requires early recognition of symptoms such as shortness of breath, persistent cough, or hypoxia, alongside careful monitoring of fluid status and cardiovascular function. Interventions may include optimized dialysis protocols, respiratory support, pharmacological management, and targeted rehabilitation to maintain lung capacity and prevent complications. Respiratory complications in kidney disease also highlight the importance of multidisciplinary care, with nephrologists, pulmonologists, critical care specialists, and respiratory therapists collaborating to provide coordinated treatment plans. Preventive strategies, including vaccination, infection control measures, and patient education on symptom recognition, are crucial in reducing morbidity and improving outcomes. Emerging research explores the impact of novel therapies and personalized approaches to mitigate pulmonary risks in patients with chronic kidney disease. By understanding the mechanisms linking renal impairment and respiratory dysfunction, healthcare providers can implement timely interventions, improve quality of life, and reduce hospitalization rates, emphasizing the need for comprehensive, proactive management of respiratory health in this vulnerable patient population.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation